Pediatric Cancer Trials

A new drug aimed at treating ATRT, the same brain tumor that affected Francesca, is currently undergoing clinical trials, with hopes it could benefit many cancers. However, the lengthy process of these trials, often taking years, highlights the stark difference in research focus between adult and pediatric cancers. Nancy's heart-wrenching experience after losing her son to cancer ignited her mission to advocate for better funding and development of pediatric cancer treatments, emphasizing the financial challenges that hinder progress in this area.